Research and Development

Halloween is creeping up, and its business as usual for the pharma industry; the week has been full of shockers, …

Adents, a French software developer for unique production identification and ‘Track & Trace’ solutions, and Microsoft have developed, with an …

Sanofi has teamed up with Brazilian research institute Fiocruz to accelerate development of a zika vaccine.This is another step in …

Teva Pharmaceuticals and IBM have announced a partnership that will use IBM Watson Health Cloud with the aim of finding …

Warwickshire-based biotech Mercia Technologies has injected a further £1 million into synthetic biology- specialist Oxford Genetics, bringing their total investment …

AstraZeneca has revealed new results from a Phase III trial investigating the efficacy of its Lynparza drug as a monotherapy …

Mylan’s recent EpiPen price inflation scandal has reignited a seemingly never-ending debate on the power of drug companies to charge …

The latest issue of Pharmafocus is now live and ready to be read! We’ve taken the opportunity to cover some of …

Nordic Nanovector has announced that they have formed a partnership with WILEX subsidiary, Heidelberg Pharma. Heidelberg Pharma specialises in the …

The Competition and Marketing Authority has launched an investigation into a number of drug companies following claims that 32 drugs …

The backlash against the over-prescription of ‘testosterone boosters’ continues in the US, with the FDA taking action to add clear …

New research from the University of Huddersfield has shed light on a new lab technique which could aid in the …

According to new findings from GlobalData, the Colombian pharmaceutical market is due to grow from $5 billion in 2015 to …

Biopharma company Alkermes has announced the success of its ALKS 5461 treatment in a Phase III study for the treatment …

Eli Lilly received the positive news that their drug, Lartruvo, has been granted accelerated approval for use in conjunction with …